Publicacións nas que colabora con MIGUEL PAYA PERIS (25)

2004

  1. Histamina y fármacos antihistamínicos. Farmacología de otros mediadores inflamatorios

    Velázquez. Farmacología Básica y Clínica (Editorial Médica Panamericana S.A.), pp. 487-500

2003

  1. Therapeutic administration of 3,4,5-trimethoxy-4′-fluorochalcone, a selective inhibitor of iNOS expression, attenuates the development of adjuvant-induced arthritis in rats

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 368, Núm. 3, pp. 225-233

  2. ttCH, a selective inhibitor of inducible nitric oxide synthase expression with antiarthritic properties

    European Journal of Pharmacology, Vol. 465, Núm. 1-2, pp. 183-189

2002

  1. Synthesis and inhibitory activity of dimethylamino-chalcone derivatives on the induction of nitric oxide synthase

    European Journal of Medicinal Chemistry, Vol. 37, Núm. 8, pp. 699-705

2000

  1. Co-regulation between cyclo-oxygenase-2 and inducible nitric oxide synthase expression in the time-course of murine inflammation

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 361, Núm. 1, pp. 98-106

1998

  1. A new cacospongionolide inhibitor of human secretory phospholipase A2 from the tyrrhenian sponge Fasciospongia cavernosa and absolute configuration of cacospongionolides

    Journal of Natural Products, Vol. 61, Núm. 7, pp. 931-935

  2. Anti-inflammatory activity in mice of extracts from Mediterranean marine invertebrates

    Life Sciences, Vol. 62, Núm. 9

  3. Suppression of leukotriene B4 and tumour necrosis factor α release in acute inflammatory responses by novel prenylated hydroquinone derivatives

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 357, Núm. 5, pp. 565-572

1997

  1. Variabilin: A dual inhibitor of human secretory and cytosolic phospholipase A2 with anti-inflammatory activity

    Journal of Pharmacology and Experimental Therapeutics, Vol. 282, Núm. 1, pp. 123-131

1996

  1. Effect of bakuchiol on leukocyte functions and some inflammatory responses in mice

    Journal of Pharmacy and Pharmacology, Vol. 48, Núm. 9, pp. 975-980

  2. Inhibition of inflammatory responses by a series of novel dolabrane derivatives

    European Journal of Pharmacology, Vol. 312, Núm. 1, pp. 97-105

  3. Inhibition of phospholipase A2 activities and some inflammatory responses by the marine product ircinin

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 354, Núm. 5, pp. 677-683

  4. Involvement of secretory phospholipase A2 activity in the zymosan rat air pouch model of inflammation

    British Journal of Pharmacology, Vol. 117, Núm. 8, pp. 1773-1779

1995

  1. A study of the novel anti-inflammatory agent florifenine topical anti-inflammatory activity and influence on arachidonic acid metabolism and neutrophil functions

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 351, Núm. 3, pp. 298-304

  2. Antinociceptive activity of filenadol on inflammatory pain

    Life Sciences, Vol. 57, Núm. 14

  3. Inhibition of inflammatory responses by epitaondiol and other marine natural products

    Life Sciences, Vol. 57, Núm. 2

1994

  1. Accelerated communication: Effects of flavonoids on Naja Naja and human recombinant synovial phospholipases A2 and inflammatory responses in mice

    Life Sciences, Vol. 54, Núm. 20

  2. Avarol and avarone, two new anti-inflammatory agents of marine origin

    European Journal of Pharmacology, Vol. 253, Núm. 1-2, pp. 75-82

  3. Effects of flavonoids on Naja naja and human recombinant synovial phospholipases A2 and inflammatory responses in mice

    Life Sciences, Vol. 54, Núm. 20

  4. Hispidulin protection against hepatotoxicity induced by bromobenzene in mice

    Life Sciences, Vol. 55, Núm. 8